Abstract
The response to drug treatment in asthma is a complex trait and is markedly variable even in patients with apparently similar clinical features. Pharmacogenomics is a study of variations of human genome characteristics as related to drug response. A traditional candidate-gene approach and genome-wide association studies have provided an increasing list of genes and variants that was associated with asthma medications. However, as phenotypic variations arises from a network of complex interactions among genetic and environmental factors, rather than individual genes, a multidisciplinary, system-level approach is required in order to understand the interrelationships among these factors. Systems biology that studies organisms as integrated and interacting networks of genes, proteins and biochemical reactions can contribute to this. It is likely that the combination of network modeling, functional validation, and integrative -Omics will be needed to move asthma pharmacogenomics closer to clinical relevance. (Allergy Asthma Respir Dis 2014;2:326-331)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.